1)Keltner JL, Thirkill CE, Yip PT:Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome:eleven new cases and a review of 51 previously published cases. J Neuroophthalmol 21:173-187, 2001
2)Berson EL, Lessell S:Paraneoplastic night blindness with malignant melanoma. Am J Ophthalmol 106:307-311, 1988
3)Milam AH, Saari JC, Jacobson SG et al:Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. Invest Ophthalmol Vis Sci 34:91-100, 1993
4)Singh AD, Milam AH, Shields CL et al:Melanoma-associated retinopathy. Am J Ophthalmol 119:369-370, 1995
5)Potter MJ, Thirkill CE, Dam OM et al:Clinical and immunocytochemical findings in a case of melanoma-associated retinopathy. Ophthalmology 106:2121−2125, 1999
6)Machida S, Ohguro H, Tateda M et al:Melanoma-associated retinopathy associated with intranasal melanoma. Doc Ophthalmol 122:191-197, 2011
7)Hanaya J, Nakamura Y, Nejima R et al:Case report of melanoma-associated retinopathy associated with positive auto-antibodies against retinal bipolar cells. Nippon Ganka Gakkai Zasshi. 115:541-546, 2011
8)Morita Y, Kimura K, Fujitsu Y et al:Autoantibodies to transient receptor potential cation channel, subfamily M, member 1 in a Japanese patient with melanoma-associated retinopathy. Jpn J Ophthalmol 58:166-171, 2014
9)日比展昭・上野真治・朴 昌華・他:診断に苦慮した症例 悪性黒色腫関連網膜症を疑われた1例.眼臨紀6:479,2013
10)Tomizuka T, Namikawa K, Higashi T:Characteristics of melanoma in Japan:a nationwide registry analysis 2011-2013. Melanoma Res 27:492-497, 2017
11)Rastrelli M, Tropea S, Rossi CR et al:Melanoma:epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo 28:1005-1011, 2014
12)Kondo M, Sanuki R, Ueno S et al:Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction. PLoS One 6:e19911, 2011
13)Alexander KR, Fishman GA, Peachey NS et al:‘On’ response defect in paraneoplastic night blindness with cutaneous malignant melanoma. Invest Ophthalmol Vis Sci 33:477-483, 1992
14)Lei B, Bush RA, Milam AH et al:Human melanoma-associated retinopathy(MAR)antibodies alter the retinal ON-response of the monkey ERG in vivo. Invest Ophthalmol Vis Sci 41:262-266, 2000
15)Roels D, Ueno S, Talianu CD et al:Unilateral cancer-associated retinopathy:diagnosis, serology and treatment. Doc Ophthalmol 135:233-240, 2017
16)Ishihara K, Saida T, Yamamoto A:Updated statistical data for malignant melanoma in Japan. Int Clin Oncol 6:109-116, 2001